Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
Here are some of the largest recent moves: LPL FINANCIAL LLC added 158,405 shares (+301.0%) to their portfolio in Q4 2024, for an estimated $2,776,839 CAPITAL MANAGEMENT CORP /VA removed 118,345 shares (-28.2%) from their portfolio in Q4 2024, for an estimated $2,074,587 ENVESTNET ASSET MANAGEMENT INC removed 76,629 shares (-34.4%) from their portfolio in Q4 2024, for an estimated $1,343,306 SUSQUEHANNA INTERNATIONAL GROUP, LLP added 71,979 shares (+128.3%) to their portfolio in Q4 2024, for an estimated $1,261,791 EAM INVESTORS, LLC added 60,243 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,056,059 683 CAPITAL MANAGEMENT, LLC added 49,500 shares (+inf%) to their portfolio in Q4 2024, for an estimated $867,735 RENAISSANCE TECHNOLOGIES LLC removed 47,300 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $829,169 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
Reid Townsend R
It is, therefore, of great interest to understand how this novel RCD pathway is regulated
